12D miR HR13_24
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Esr2
|
ENSMUSG00000021055.7 | estrogen receptor 2 (beta) |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Esr2 | mm10_v2_chr12_-_76177251_76177265 | -0.40 | 2.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_45204083 | 2.77 |
ENSMUST00000034599.8
|
Tmprss4
|
transmembrane protease, serine 4 |
chr7_-_128206346 | 2.60 |
ENSMUST00000033049.7
|
Cox6a2
|
cytochrome c oxidase subunit VIa polypeptide 2 |
chr11_+_69965396 | 2.35 |
ENSMUST00000018713.6
|
Cldn7
|
claudin 7 |
chr16_+_5007306 | 2.20 |
ENSMUST00000178155.2
ENSMUST00000184256.1 ENSMUST00000185147.1 |
Smim22
|
small integral membrane protein 22 |
chr11_-_31824463 | 2.17 |
ENSMUST00000129425.1
ENSMUST00000126265.1 |
D630024D03Rik
|
RIKEN cDNA D630024D03 gene |
chr16_+_30008657 | 2.02 |
ENSMUST00000181485.1
|
4632428C04Rik
|
RIKEN cDNA 4632428C04 gene |
chr11_+_68556186 | 1.92 |
ENSMUST00000053211.6
|
Mfsd6l
|
major facilitator superfamily domain containing 6-like |
chr16_+_5007283 | 1.87 |
ENSMUST00000184439.1
|
Smim22
|
small integral membrane protein 22 |
chr11_+_69964758 | 1.83 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr11_-_102107822 | 1.74 |
ENSMUST00000177304.1
ENSMUST00000017455.8 |
Pyy
|
peptide YY |
chr5_+_35056813 | 1.49 |
ENSMUST00000101298.2
ENSMUST00000114270.1 ENSMUST00000133381.1 |
Dok7
|
docking protein 7 |
chr2_-_25196759 | 1.49 |
ENSMUST00000081869.6
|
Tor4a
|
torsin family 4, member A |
chr1_-_9967932 | 1.48 |
ENSMUST00000185184.1
|
Tcf24
|
transcription factor 24 |
chr2_-_62483637 | 1.48 |
ENSMUST00000136686.1
ENSMUST00000102733.3 |
Gcg
|
glucagon |
chr4_+_40473130 | 1.47 |
ENSMUST00000179526.1
|
Tmem215
|
transmembrane protein 215 |
chr16_+_31878810 | 1.46 |
ENSMUST00000023464.5
|
Mfi2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
chr7_-_3677509 | 1.41 |
ENSMUST00000038743.8
|
Tmc4
|
transmembrane channel-like gene family 4 |
chr2_-_129699833 | 1.34 |
ENSMUST00000028883.5
|
Pdyn
|
prodynorphin |
chr4_+_128058962 | 1.31 |
ENSMUST00000184063.1
|
Csmd2
|
CUB and Sushi multiple domains 2 |
chr11_-_119086221 | 1.28 |
ENSMUST00000026665.7
|
Cbx4
|
chromobox 4 |
chr2_+_59484645 | 1.28 |
ENSMUST00000028369.5
|
Dapl1
|
death associated protein-like 1 |
chr4_+_115088708 | 1.27 |
ENSMUST00000171877.1
ENSMUST00000177647.1 ENSMUST00000106548.2 ENSMUST00000030488.2 |
Pdzk1ip1
|
PDZK1 interacting protein 1 |
chr7_-_46179929 | 1.25 |
ENSMUST00000033123.6
|
Abcc8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
chr8_+_95320440 | 1.24 |
ENSMUST00000162294.1
|
Tepp
|
testis, prostate and placenta expressed |
chr4_-_138367966 | 1.24 |
ENSMUST00000030535.3
|
Cda
|
cytidine deaminase |
chr11_+_120530688 | 1.23 |
ENSMUST00000026119.7
|
Gcgr
|
glucagon receptor |
chr7_-_127890918 | 1.20 |
ENSMUST00000121394.1
|
Prss53
|
protease, serine, 53 |
chr8_+_70724064 | 1.17 |
ENSMUST00000034307.7
ENSMUST00000110095.2 |
Pde4c
|
phosphodiesterase 4C, cAMP specific |
chr4_+_106733883 | 1.16 |
ENSMUST00000047620.2
|
Fam151a
|
family with sequence simliarity 151, member A |
chr13_-_34345174 | 1.16 |
ENSMUST00000040336.5
|
Slc22a23
|
solute carrier family 22, member 23 |
chr17_-_57000018 | 1.15 |
ENSMUST00000002740.2
|
Pspn
|
persephin |
chr6_-_5256226 | 1.15 |
ENSMUST00000125686.1
ENSMUST00000031773.2 |
Pon3
|
paraoxonase 3 |
chr13_-_3945349 | 1.11 |
ENSMUST00000058610.7
|
Ucn3
|
urocortin 3 |
chr8_+_84415348 | 1.11 |
ENSMUST00000121390.1
ENSMUST00000122053.1 |
Cacna1a
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr13_-_9878998 | 1.09 |
ENSMUST00000063093.9
|
Chrm3
|
cholinergic receptor, muscarinic 3, cardiac |
chr6_-_124733121 | 1.09 |
ENSMUST00000112484.3
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr5_+_35057059 | 1.09 |
ENSMUST00000050709.3
|
Dok7
|
docking protein 7 |
chr4_+_120666562 | 1.08 |
ENSMUST00000094814.4
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr1_-_158814469 | 1.07 |
ENSMUST00000161589.2
|
Pappa2
|
pappalysin 2 |
chr15_+_10177623 | 1.07 |
ENSMUST00000124470.1
|
Prlr
|
prolactin receptor |
chr7_+_19083842 | 1.06 |
ENSMUST00000032568.7
ENSMUST00000122999.1 ENSMUST00000108473.3 ENSMUST00000108474.1 |
Dmpk
|
dystrophia myotonica-protein kinase |
chr18_+_77185815 | 1.04 |
ENSMUST00000079618.4
|
St8sia5
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
chr4_+_141242850 | 1.04 |
ENSMUST00000138096.1
ENSMUST00000006618.2 ENSMUST00000125392.1 |
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr12_+_112620030 | 1.02 |
ENSMUST00000180015.1
ENSMUST00000021726.6 |
Adssl1
|
adenylosuccinate synthetase like 1 |
chr8_-_72212837 | 1.02 |
ENSMUST00000098630.3
|
Cib3
|
calcium and integrin binding family member 3 |
chr10_-_77259223 | 1.02 |
ENSMUST00000105408.3
|
Gm10941
|
predicted gene 10941 |
chr11_-_31824518 | 1.00 |
ENSMUST00000134944.1
|
D630024D03Rik
|
RIKEN cDNA D630024D03 gene |
chr3_-_88548249 | 1.00 |
ENSMUST00000131775.1
ENSMUST00000008745.6 |
Rab25
|
RAB25, member RAS oncogene family |
chr4_+_82065855 | 0.99 |
ENSMUST00000151038.1
|
Gm5860
|
predicted gene 5860 |
chr15_-_101370125 | 0.97 |
ENSMUST00000077196.4
|
Krt80
|
keratin 80 |
chr9_+_111019284 | 0.97 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr6_+_90619241 | 0.96 |
ENSMUST00000032177.8
|
Slc41a3
|
solute carrier family 41, member 3 |
chr15_-_66560997 | 0.96 |
ENSMUST00000048372.5
|
Tmem71
|
transmembrane protein 71 |
chr13_+_38345716 | 0.95 |
ENSMUST00000171970.1
|
Bmp6
|
bone morphogenetic protein 6 |
chr2_-_127270032 | 0.93 |
ENSMUST00000099407.1
|
Gm10766
|
predicted gene 10766 |
chr9_-_121792478 | 0.93 |
ENSMUST00000035110.4
|
Hhatl
|
hedgehog acyltransferase-like |
chr12_+_112678803 | 0.93 |
ENSMUST00000174780.1
ENSMUST00000169593.1 ENSMUST00000173942.1 |
Zbtb42
|
zinc finger and BTB domain containing 42 |
chr16_+_97356721 | 0.92 |
ENSMUST00000047275.6
|
Bace2
|
beta-site APP-cleaving enzyme 2 |
chr3_+_146117451 | 0.92 |
ENSMUST00000140214.1
|
Mcoln3
|
mucolipin 3 |
chr10_+_115817247 | 0.92 |
ENSMUST00000035563.7
ENSMUST00000080630.3 ENSMUST00000179196.1 |
Tspan8
|
tetraspanin 8 |
chr7_+_49974864 | 0.91 |
ENSMUST00000081872.5
ENSMUST00000151721.1 |
Nell1
|
NEL-like 1 |
chr17_+_57062231 | 0.91 |
ENSMUST00000097299.3
ENSMUST00000169543.1 ENSMUST00000163763.1 |
Crb3
|
crumbs homolog 3 (Drosophila) |
chr2_-_144331695 | 0.91 |
ENSMUST00000103171.3
|
Ovol2
|
ovo-like 2 (Drosophila) |
chr7_+_122219469 | 0.90 |
ENSMUST00000033152.4
|
Chp2
|
calcineurin-like EF hand protein 2 |
chr16_-_23890805 | 0.90 |
ENSMUST00000004480.3
|
Sst
|
somatostatin |
chr16_+_32735886 | 0.89 |
ENSMUST00000132475.1
ENSMUST00000096106.3 |
Muc4
|
mucin 4 |
chr7_-_44816586 | 0.88 |
ENSMUST00000047356.8
|
Atf5
|
activating transcription factor 5 |
chr5_+_16553488 | 0.88 |
ENSMUST00000030683.3
|
Hgf
|
hepatocyte growth factor |
chr19_-_6996025 | 0.88 |
ENSMUST00000041686.3
ENSMUST00000180765.1 |
Nudt22
|
nudix (nucleoside diphosphate linked moiety X)-type motif 22 |
chr4_+_148643317 | 0.86 |
ENSMUST00000105698.2
|
Gm572
|
predicted gene 572 |
chr5_+_66968416 | 0.86 |
ENSMUST00000038188.7
|
Limch1
|
LIM and calponin homology domains 1 |
chr5_+_30913398 | 0.85 |
ENSMUST00000031055.5
|
Emilin1
|
elastin microfibril interfacer 1 |
chr17_+_30901811 | 0.85 |
ENSMUST00000114574.1
|
Glp1r
|
glucagon-like peptide 1 receptor |
chr6_-_6217023 | 0.84 |
ENSMUST00000015256.8
|
Slc25a13
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
chrX_-_106011874 | 0.84 |
ENSMUST00000033583.7
ENSMUST00000151689.1 |
Magt1
|
magnesium transporter 1 |
chr4_+_143349757 | 0.84 |
ENSMUST00000052458.2
|
Lrrc38
|
leucine rich repeat containing 38 |
chr7_-_66427469 | 0.83 |
ENSMUST00000015278.7
|
Aldh1a3
|
aldehyde dehydrogenase family 1, subfamily A3 |
chr17_-_36168507 | 0.82 |
ENSMUST00000097335.3
ENSMUST00000173353.1 |
Gm8909
|
predicted gene 8909 |
chr10_+_34483400 | 0.82 |
ENSMUST00000019913.7
ENSMUST00000170771.1 |
Frk
|
fyn-related kinase |
chr17_-_36168532 | 0.82 |
ENSMUST00000040467.8
|
Gm8909
|
predicted gene 8909 |
chr16_-_32797413 | 0.81 |
ENSMUST00000115116.1
ENSMUST00000041123.8 |
Muc20
|
mucin 20 |
chr11_+_4236411 | 0.81 |
ENSMUST00000075221.2
|
Osm
|
oncostatin M |
chr6_-_124769548 | 0.80 |
ENSMUST00000149652.1
ENSMUST00000112476.1 ENSMUST00000004378.8 |
Eno2
|
enolase 2, gamma neuronal |
chr9_+_54699548 | 0.80 |
ENSMUST00000070070.7
|
Dnaja4
|
DnaJ (Hsp40) homolog, subfamily A, member 4 |
chr3_+_94933041 | 0.80 |
ENSMUST00000090839.5
|
Selenbp1
|
selenium binding protein 1 |
chr5_+_149439706 | 0.79 |
ENSMUST00000031667.4
|
Tex26
|
testis expressed 26 |
chr3_-_84480419 | 0.79 |
ENSMUST00000107689.1
|
Fhdc1
|
FH2 domain containing 1 |
chr4_+_104766308 | 0.79 |
ENSMUST00000031663.3
|
C8b
|
complement component 8, beta polypeptide |
chr1_+_90915064 | 0.79 |
ENSMUST00000027528.6
|
Mlph
|
melanophilin |
chr13_+_18948344 | 0.79 |
ENSMUST00000003345.7
|
Amph
|
amphiphysin |
chr19_-_6015152 | 0.78 |
ENSMUST00000025891.8
|
Capn1
|
calpain 1 |
chr7_-_100662315 | 0.78 |
ENSMUST00000151123.1
ENSMUST00000107047.2 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr17_-_24689901 | 0.77 |
ENSMUST00000007236.4
|
Syngr3
|
synaptogyrin 3 |
chr10_+_81643797 | 0.77 |
ENSMUST00000132458.1
|
Ankrd24
|
ankyrin repeat domain 24 |
chr2_+_156312299 | 0.77 |
ENSMUST00000037096.2
|
Cnbd2
|
cyclic nucleotide binding domain containing 2 |
chr7_+_28440927 | 0.77 |
ENSMUST00000078845.6
|
Gmfg
|
glia maturation factor, gamma |
chr16_+_36694024 | 0.77 |
ENSMUST00000119464.1
|
Ildr1
|
immunoglobulin-like domain containing receptor 1 |
chr8_+_76902277 | 0.77 |
ENSMUST00000109912.1
ENSMUST00000128862.1 ENSMUST00000109911.1 |
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr8_+_10006656 | 0.76 |
ENSMUST00000033892.7
|
Tnfsf13b
|
tumor necrosis factor (ligand) superfamily, member 13b |
chr3_+_122729158 | 0.76 |
ENSMUST00000066728.5
|
Pde5a
|
phosphodiesterase 5A, cGMP-specific |
chr11_-_102101310 | 0.75 |
ENSMUST00000170554.2
ENSMUST00000017460.5 |
Ppy
|
pancreatic polypeptide |
chr3_+_103575275 | 0.75 |
ENSMUST00000090697.4
|
Syt6
|
synaptotagmin VI |
chr17_+_32468462 | 0.75 |
ENSMUST00000003413.6
|
Cyp4f39
|
cytochrome P450, family 4, subfamily f, polypeptide 39 |
chr11_+_113619318 | 0.74 |
ENSMUST00000146390.2
ENSMUST00000106630.1 |
Sstr2
|
somatostatin receptor 2 |
chr2_+_24385313 | 0.73 |
ENSMUST00000056641.8
|
Psd4
|
pleckstrin and Sec7 domain containing 4 |
chr1_-_84696182 | 0.73 |
ENSMUST00000049126.6
|
Dner
|
delta/notch-like EGF-related receptor |
chr7_-_46238464 | 0.73 |
ENSMUST00000154292.2
ENSMUST00000078680.6 ENSMUST00000177212.1 ENSMUST00000009667.5 |
Ush1c
|
Usher syndrome 1C |
chr4_-_148152059 | 0.73 |
ENSMUST00000056965.5
ENSMUST00000168503.1 ENSMUST00000152098.1 |
Fbxo6
|
F-box protein 6 |
chr17_+_33920522 | 0.72 |
ENSMUST00000172489.1
|
Tapbp
|
TAP binding protein |
chr14_+_41131777 | 0.72 |
ENSMUST00000022314.3
ENSMUST00000170719.1 |
Sftpa1
|
surfactant associated protein A1 |
chr7_-_100656953 | 0.72 |
ENSMUST00000107046.1
ENSMUST00000107045.1 ENSMUST00000139708.1 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr7_-_126625676 | 0.72 |
ENSMUST00000032961.3
|
Nupr1
|
nuclear protein transcription regulator 1 |
chr10_+_95417352 | 0.72 |
ENSMUST00000181781.1
|
5730420D15Rik
|
RIKEN cDNA 5730420D15 gene |
chr2_+_170731807 | 0.72 |
ENSMUST00000029075.4
|
Dok5
|
docking protein 5 |
chr17_+_57062486 | 0.72 |
ENSMUST00000163628.1
|
Crb3
|
crumbs homolog 3 (Drosophila) |
chr10_-_60938123 | 0.72 |
ENSMUST00000036304.3
|
Pldi
|
polymorphic derived intron containing |
chr6_+_96115249 | 0.72 |
ENSMUST00000075080.5
|
Fam19a1
|
family with sequence similarity 19, member A1 |
chr2_-_180334665 | 0.72 |
ENSMUST00000015771.2
|
Gata5
|
GATA binding protein 5 |
chr6_+_90550789 | 0.71 |
ENSMUST00000130418.1
ENSMUST00000032175.8 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr11_+_16752203 | 0.70 |
ENSMUST00000102884.3
ENSMUST00000020329.6 |
Egfr
|
epidermal growth factor receptor |
chr4_+_49059256 | 0.70 |
ENSMUST00000076670.2
|
E130309F12Rik
|
RIKEN cDNA E130309F12 gene |
chr4_-_148500449 | 0.70 |
ENSMUST00000030840.3
|
Angptl7
|
angiopoietin-like 7 |
chr4_+_106622424 | 0.69 |
ENSMUST00000047922.2
|
Ttc22
|
tetratricopeptide repeat domain 22 |
chr2_-_93452679 | 0.69 |
ENSMUST00000111257.1
ENSMUST00000145553.1 |
Cd82
|
CD82 antigen |
chr15_+_10358525 | 0.69 |
ENSMUST00000110540.1
ENSMUST00000110541.1 ENSMUST00000110542.1 |
Agxt2
|
alanine-glyoxylate aminotransferase 2 |
chr1_+_40266578 | 0.69 |
ENSMUST00000114795.1
|
Il1r1
|
interleukin 1 receptor, type I |
chr5_+_64970069 | 0.69 |
ENSMUST00000031080.8
|
Fam114a1
|
family with sequence similarity 114, member A1 |
chr5_+_90759299 | 0.68 |
ENSMUST00000031318.4
|
Cxcl5
|
chemokine (C-X-C motif) ligand 5 |
chr1_-_172632931 | 0.68 |
ENSMUST00000027826.5
|
Dusp23
|
dual specificity phosphatase 23 |
chr7_-_143074037 | 0.68 |
ENSMUST00000136602.1
|
Trpm5
|
transient receptor potential cation channel, subfamily M, member 5 |
chr11_-_3931960 | 0.68 |
ENSMUST00000109990.1
ENSMUST00000020710.4 ENSMUST00000109989.3 ENSMUST00000109991.1 ENSMUST00000109993.2 |
Tcn2
|
transcobalamin 2 |
chr17_+_34203527 | 0.67 |
ENSMUST00000025197.5
|
Tap2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
chr4_-_11386679 | 0.67 |
ENSMUST00000043781.7
ENSMUST00000108310.1 |
Esrp1
|
epithelial splicing regulatory protein 1 |
chr16_+_36693972 | 0.67 |
ENSMUST00000023617.6
ENSMUST00000089618.3 |
Ildr1
|
immunoglobulin-like domain containing receptor 1 |
chr10_+_127866457 | 0.66 |
ENSMUST00000092058.3
|
BC089597
|
cDNA sequence BC089597 |
chr13_+_38151343 | 0.66 |
ENSMUST00000124830.1
|
Dsp
|
desmoplakin |
chr4_+_41762309 | 0.66 |
ENSMUST00000108042.2
|
Il11ra1
|
interleukin 11 receptor, alpha chain 1 |
chr19_-_6980420 | 0.66 |
ENSMUST00000070878.8
ENSMUST00000177752.1 |
Fkbp2
|
FK506 binding protein 2 |
chr7_-_30821139 | 0.66 |
ENSMUST00000163504.1
|
Ffar2
|
free fatty acid receptor 2 |
chr12_+_112808914 | 0.66 |
ENSMUST00000037014.3
ENSMUST00000177808.1 |
BC022687
|
cDNA sequence BC022687 |
chr7_-_3915501 | 0.66 |
ENSMUST00000038176.8
ENSMUST00000090689.4 |
Lilra6
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 |
chr4_-_141846277 | 0.66 |
ENSMUST00000105781.1
|
Ctrc
|
chymotrypsin C (caldecrin) |
chr1_+_134193432 | 0.65 |
ENSMUST00000038445.6
|
Mybph
|
myosin binding protein H |
chr7_-_101868667 | 0.65 |
ENSMUST00000150184.1
|
Folr1
|
folate receptor 1 (adult) |
chr5_-_93045022 | 0.65 |
ENSMUST00000061328.5
|
Sowahb
|
sosondowah ankyrin repeat domain family member B |
chr19_-_42752710 | 0.65 |
ENSMUST00000076505.3
|
Pyroxd2
|
pyridine nucleotide-disulphide oxidoreductase domain 2 |
chr11_-_114795888 | 0.65 |
ENSMUST00000000206.3
|
Btbd17
|
BTB (POZ) domain containing 17 |
chr7_-_19796789 | 0.65 |
ENSMUST00000108449.2
ENSMUST00000043822.7 |
Cblc
|
Casitas B-lineage lymphoma c |
chr2_-_66568312 | 0.65 |
ENSMUST00000112354.1
|
Scn9a
|
sodium channel, voltage-gated, type IX, alpha |
chr3_+_105870898 | 0.64 |
ENSMUST00000010279.5
|
Adora3
|
adenosine A3 receptor |
chr8_-_54529951 | 0.64 |
ENSMUST00000067476.8
|
Spcs3
|
signal peptidase complex subunit 3 homolog (S. cerevisiae) |
chr4_+_120161206 | 0.64 |
ENSMUST00000030384.4
|
Edn2
|
endothelin 2 |
chr8_-_71701796 | 0.64 |
ENSMUST00000034260.7
|
B3gnt3
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
chr15_+_7129557 | 0.64 |
ENSMUST00000067190.5
ENSMUST00000164529.1 |
Lifr
|
leukemia inhibitory factor receptor |
chr18_-_56925509 | 0.63 |
ENSMUST00000102912.1
|
March3
|
membrane-associated ring finger (C3HC4) 3 |
chr2_+_174760619 | 0.63 |
ENSMUST00000029030.2
|
Edn3
|
endothelin 3 |
chr4_-_126533472 | 0.62 |
ENSMUST00000084289.4
|
Ago4
|
argonaute RISC catalytic subunit 4 |
chr17_+_5492558 | 0.62 |
ENSMUST00000089185.4
|
Zdhhc14
|
zinc finger, DHHC domain containing 14 |
chr9_-_77544829 | 0.62 |
ENSMUST00000183734.1
|
Lrrc1
|
leucine rich repeat containing 1 |
chrX_+_73123068 | 0.62 |
ENSMUST00000179117.1
|
Gm14685
|
predicted gene 14685 |
chr12_+_69790288 | 0.62 |
ENSMUST00000021378.3
|
4930512B01Rik
|
RIKEN cDNA 4930512B01 gene |
chr14_+_59625281 | 0.62 |
ENSMUST00000053949.5
|
Shisa2
|
shisa homolog 2 (Xenopus laevis) |
chr18_+_74442551 | 0.62 |
ENSMUST00000121875.1
|
Myo5b
|
myosin VB |
chr9_+_35211155 | 0.61 |
ENSMUST00000034541.5
|
Srpr
|
signal recognition particle receptor ('docking protein') |
chr10_+_60277627 | 0.61 |
ENSMUST00000105465.1
ENSMUST00000177779.1 ENSMUST00000179238.1 ENSMUST00000004316.8 |
Psap
|
prosaposin |
chr7_-_100662414 | 0.61 |
ENSMUST00000079176.6
|
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr11_+_58379036 | 0.61 |
ENSMUST00000013787.4
ENSMUST00000108826.2 |
Lypd8
|
LY6/PLAUR domain containing 8 |
chr7_-_79793788 | 0.61 |
ENSMUST00000032760.5
|
Mesp1
|
mesoderm posterior 1 |
chr7_+_121734477 | 0.61 |
ENSMUST00000000221.5
|
Scnn1g
|
sodium channel, nonvoltage-gated 1 gamma |
chr9_-_21989427 | 0.61 |
ENSMUST00000045726.6
|
Rgl3
|
ral guanine nucleotide dissociation stimulator-like 3 |
chr8_+_76899772 | 0.61 |
ENSMUST00000109913.2
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr12_-_17176888 | 0.61 |
ENSMUST00000170580.1
|
Kcnf1
|
potassium voltage-gated channel, subfamily F, member 1 |
chr4_-_117872520 | 0.61 |
ENSMUST00000171052.1
ENSMUST00000166325.1 ENSMUST00000106422.2 |
Ccdc24
|
coiled-coil domain containing 24 |
chr19_+_4081565 | 0.61 |
ENSMUST00000159593.1
|
Cabp2
|
calcium binding protein 2 |
chr5_+_66968559 | 0.61 |
ENSMUST00000127184.1
|
Limch1
|
LIM and calponin homology domains 1 |
chr7_-_134938264 | 0.60 |
ENSMUST00000171394.1
|
Fam196a
|
family with sequence similarity 196, member A |
chr4_-_106799779 | 0.60 |
ENSMUST00000145061.1
ENSMUST00000102762.3 |
Acot11
|
acyl-CoA thioesterase 11 |
chrX_-_106011766 | 0.60 |
ENSMUST00000139421.1
ENSMUST00000113566.2 |
Magt1
|
magnesium transporter 1 |
chr10_+_62133082 | 0.60 |
ENSMUST00000050103.1
|
Neurog3
|
neurogenin 3 |
chr12_-_86988676 | 0.60 |
ENSMUST00000095521.2
|
Zdhhc22
|
zinc finger, DHHC-type containing 22 |
chr11_-_72135721 | 0.60 |
ENSMUST00000108508.2
ENSMUST00000075258.6 |
Pitpnm3
|
PITPNM family member 3 |
chr11_+_9048575 | 0.60 |
ENSMUST00000043285.4
|
Gm11992
|
predicted gene 11992 |
chr16_+_22857845 | 0.60 |
ENSMUST00000004574.7
ENSMUST00000178320.1 ENSMUST00000166487.2 |
Dnajb11
|
DnaJ (Hsp40) homolog, subfamily B, member 11 |
chr3_-_89093358 | 0.59 |
ENSMUST00000090929.5
ENSMUST00000052539.6 |
Rusc1
|
RUN and SH3 domain containing 1 |
chr6_+_5390387 | 0.59 |
ENSMUST00000183358.1
|
Asb4
|
ankyrin repeat and SOCS box-containing 4 |
chr16_-_17838173 | 0.59 |
ENSMUST00000118960.1
|
Car15
|
carbonic anhydrase 15 |
chr5_+_24423851 | 0.59 |
ENSMUST00000141966.1
|
Slc4a2
|
solute carrier family 4 (anion exchanger), member 2 |
chr2_+_155381808 | 0.59 |
ENSMUST00000043237.7
ENSMUST00000174685.1 |
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr9_-_96437434 | 0.59 |
ENSMUST00000070500.2
|
BC043934
|
cDNA sequence BC043934 |
chr5_-_139814231 | 0.59 |
ENSMUST00000044002.4
|
Tmem184a
|
transmembrane protein 184a |
chr3_+_145292472 | 0.59 |
ENSMUST00000029848.4
ENSMUST00000139001.1 |
Col24a1
|
collagen, type XXIV, alpha 1 |
chr3_+_138277489 | 0.59 |
ENSMUST00000004232.9
|
Adh1
|
alcohol dehydrogenase 1 (class I) |
chr4_-_107307118 | 0.59 |
ENSMUST00000126291.1
ENSMUST00000106748.1 ENSMUST00000129138.1 ENSMUST00000082426.3 |
Dio1
|
deiodinase, iodothyronine, type I |
chr18_-_34007206 | 0.58 |
ENSMUST00000025234.5
|
Epb4.1l4a
|
erythrocyte protein band 4.1-like 4a |
chr17_+_17831004 | 0.58 |
ENSMUST00000172097.2
|
4930546H06Rik
|
RIKEN cDNA 4930546H06 gene |
chr15_+_102102926 | 0.58 |
ENSMUST00000169627.1
ENSMUST00000046144.9 |
Tenc1
|
tensin like C1 domain-containing phosphatase |
chr5_+_122707546 | 0.58 |
ENSMUST00000081554.6
ENSMUST00000031429.7 ENSMUST00000139631.1 ENSMUST00000142664.1 |
P2rx4
|
purinergic receptor P2X, ligand-gated ion channel 4 |
chr15_+_54571358 | 0.58 |
ENSMUST00000025356.2
|
Mal2
|
mal, T cell differentiation protein 2 |
chr4_-_129614254 | 0.58 |
ENSMUST00000106037.2
ENSMUST00000179209.1 |
Dcdc2b
|
doublecortin domain containing 2b |
chr9_+_43744399 | 0.58 |
ENSMUST00000034510.7
|
Pvrl1
|
poliovirus receptor-related 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.5 | 1.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.5 | 1.4 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.4 | 1.3 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 1.3 | GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-alanine catabolic process(GO:0042853) |
0.4 | 1.2 | GO:0071846 | actin filament debranching(GO:0071846) |
0.4 | 2.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.4 | 1.1 | GO:0033189 | response to vitamin A(GO:0033189) |
0.3 | 1.0 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.3 | 1.9 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.3 | 1.2 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.3 | 1.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 4.5 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.3 | 0.8 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 1.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 1.1 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.3 | 1.5 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 1.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.3 | 0.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 1.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 0.8 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 4.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 0.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 0.7 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
0.2 | 0.7 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.2 | 1.0 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.2 | 0.7 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.2 | 0.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 0.7 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.2 | 0.7 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.2 | 0.7 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 0.7 | GO:0046968 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) peptide antigen transport(GO:0046968) |
0.2 | 0.7 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.2 | 0.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 0.9 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.2 | 0.7 | GO:0002879 | cell surface pattern recognition receptor signaling pathway(GO:0002752) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.2 | 0.4 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.2 | 1.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.2 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.6 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.2 | 1.3 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 2.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.6 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.2 | 0.2 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.2 | 0.2 | GO:1902861 | copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
0.2 | 0.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.2 | 1.5 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.4 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 0.6 | GO:0003285 | septum secundum development(GO:0003285) cardiac muscle tissue regeneration(GO:0061026) negative regulation of connective tissue replacement(GO:1905204) |
0.2 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.4 | GO:0051794 | regulation of catagen(GO:0051794) |
0.2 | 1.2 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.2 | 0.6 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.2 | 1.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 1.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.6 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.2 | 0.8 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.6 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 0.6 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 1.7 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.6 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.2 | 1.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 1.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 0.9 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.2 | 2.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 1.3 | GO:2001199 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 0.5 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.2 | 1.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 1.9 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.2 | 1.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 0.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.2 | 1.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.5 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.2 | 0.7 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.2 | 0.5 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.2 | 0.7 | GO:0060376 | positive regulation of mast cell differentiation(GO:0060376) |
0.2 | 0.8 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.2 | GO:1902943 | regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) |
0.2 | 0.5 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 0.8 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 2.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.3 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.2 | 1.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.5 | GO:0006571 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
0.2 | 0.6 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 0.5 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.2 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.3 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.2 | 0.9 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.6 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.5 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 0.6 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 0.4 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.4 | GO:0001192 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.1 | 0.4 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.1 | 1.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 0.6 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 2.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.4 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.1 | 0.7 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 0.5 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.1 | 0.5 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.4 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 0.4 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 0.3 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 1.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.6 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 1.1 | GO:0060974 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.1 | 0.5 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.1 | 0.5 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.4 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.4 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.1 | 0.6 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.4 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.1 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 2.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 1.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.2 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.9 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.3 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.3 | GO:0036088 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.1 | 0.5 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.3 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.8 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.3 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.3 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.1 | 0.3 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.6 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.1 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.1 | 0.9 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.6 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.1 | 0.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.3 | GO:0072343 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.1 | 0.4 | GO:0061235 | regulation of pronephros size(GO:0035565) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
0.1 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.5 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.3 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.1 | 3.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 1.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.3 | GO:0003127 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.1 | 0.5 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.1 | 0.2 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.1 | 0.5 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.2 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.1 | 0.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.4 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.9 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.5 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 0.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.1 | 0.3 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.1 | 0.3 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.1 | 0.1 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.3 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 1.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 0.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.3 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.1 | 0.5 | GO:0034238 | macrophage fusion(GO:0034238) |
0.1 | 0.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.3 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.1 | 0.4 | GO:1902856 | microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.1 | 0.3 | GO:0015881 | creatine transport(GO:0015881) |
0.1 | 1.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.2 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.2 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.4 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.2 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.1 | 0.4 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.1 | 0.7 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.1 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 1.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.3 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 1.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.8 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.3 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.1 | 0.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.1 | 0.1 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.1 | 0.1 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
0.1 | 0.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.2 | GO:0097117 | guanylate kinase-associated protein clustering(GO:0097117) |
0.1 | 0.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 1.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 1.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.6 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.6 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.2 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.1 | 1.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.6 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 1.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.2 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.1 | 0.6 | GO:0033216 | ferric iron import(GO:0033216) |
0.1 | 0.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.5 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.3 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.4 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 1.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 2.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 2.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.1 | 0.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.3 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.3 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.2 | GO:0072299 | negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.1 | 4.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.3 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 0.2 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 0.2 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.3 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.4 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.3 | GO:0034759 | regulation of iron ion transport(GO:0034756) negative regulation of iron ion transport(GO:0034757) regulation of iron ion transmembrane transport(GO:0034759) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.1 | 0.2 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.1 | 0.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.1 | 0.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.1 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.1 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.1 | 0.1 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.1 | 0.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.1 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) extrathymic T cell selection(GO:0045062) |
0.1 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.5 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 1.1 | GO:0051645 | Golgi localization(GO:0051645) |
0.1 | 0.4 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.1 | 0.3 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.2 | GO:0002631 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) tolerance induction to lipopolysaccharide(GO:0072573) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 1.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.8 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.8 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 0.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.2 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.2 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 0.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.2 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.1 | 0.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 1.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 0.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.1 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 0.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.1 | 0.5 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.9 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.1 | 0.2 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.1 | 0.2 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.1 | 0.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 0.2 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.1 | 0.2 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.1 | 0.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.2 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.1 | 0.2 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.2 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.6 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.4 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.1 | 0.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.2 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.1 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.3 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.1 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.2 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.1 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.2 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
0.1 | 0.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.2 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.1 | 0.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.1 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.1 | 0.2 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
0.1 | 0.3 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.3 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.1 | 0.4 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.0 | 0.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.0 | 0.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.3 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.0 | 1.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
0.0 | 0.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 1.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.0 | 0.0 | GO:1903296 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.0 | 0.1 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) circadian regulation of translation(GO:0097167) |
0.0 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 0.2 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.0 | 0.0 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.0 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.0 | 0.2 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.7 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.2 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.0 | 0.2 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.1 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.8 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.2 | GO:0046898 | synaptic vesicle recycling via endosome(GO:0036466) response to cycloheximide(GO:0046898) |
0.0 | 0.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.2 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.0 | 0.2 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.0 | 0.3 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.0 | 0.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.0 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.2 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.0 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.0 | 0.2 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.0 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.2 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.2 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.0 | 0.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.4 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.0 | 0.1 | GO:0035702 | monocyte homeostasis(GO:0035702) |
0.0 | 0.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 1.0 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 1.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.6 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.0 | 0.2 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.0 | 0.2 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.0 | 0.1 | GO:1904580 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) regulation of intracellular mRNA localization(GO:1904580) |
0.0 | 0.7 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.1 | GO:0007314 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.0 | 1.4 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.0 | 0.2 | GO:1904720 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.0 | 0.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.1 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.0 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.0 | GO:0052405 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.1 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.0 | 0.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.0 | 0.1 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.0 | 0.2 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.0 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.2 | GO:0002580 | negative regulation of antigen processing and presentation(GO:0002578) regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.0 | 0.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.0 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 1.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.0 | 0.1 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.0 | 0.2 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.2 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.5 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.2 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.0 | 0.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.1 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
0.0 | 0.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.0 | 0.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.1 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.0 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.0 | 0.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 2.5 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.4 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.2 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.0 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.0 | 0.1 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.0 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.0 | 0.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.0 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.4 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.0 | 0.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.1 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.0 | 0.4 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.0 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.3 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.0 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.0 | 0.4 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.1 | GO:0009816 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.0 | 0.2 | GO:0046755 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.0 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.1 | GO:0009744 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.0 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.0 | 0.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.0 | 0.1 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.0 | 0.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.0 | 0.1 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.0 | 0.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.2 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.1 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.2 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.1 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.0 | 0.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.1 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.0 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.1 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.0 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.0 | 0.1 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.1 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.2 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.0 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.0 | 0.4 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.0 | 0.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.1 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.0 | 0.8 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.1 | GO:0002325 | peptidoglycan metabolic process(GO:0000270) natural killer cell differentiation involved in immune response(GO:0002325) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.0 | 0.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 0.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.0 | 0.1 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.0 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.0 | 0.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0002423 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.1 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
0.0 | 0.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.0 | 0.0 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.0 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.6 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.0 | 0.3 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.1 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.0 | 0.0 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.0 | 0.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.0 | GO:0015677 | copper ion import(GO:0015677) copper ion export(GO:0060003) |
0.0 | 0.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.4 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.0 | 0.0 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.0 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.5 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.0 | 0.1 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.0 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 | 0.4 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.2 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.2 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 1.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.0 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.2 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.2 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.1 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.0 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.0 | 0.1 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) |
0.0 | 0.0 | GO:0015811 | L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.3 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.1 | GO:1901630 | positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) negative regulation of presynaptic membrane organization(GO:1901630) regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) positive regulation of receptor catabolic process(GO:2000646) |
0.0 | 0.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.2 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.2 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.0 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.4 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.0 | 0.2 | GO:0035634 | response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 0.1 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.0 | 0.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0010043 | response to zinc ion(GO:0010043) |
0.0 | 0.0 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.2 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.1 | GO:0060718 | chorion development(GO:0060717) chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.0 | GO:0061193 | taste bud development(GO:0061193) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.0 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.0 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.0 | 0.1 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.0 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.0 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.3 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.0 | GO:0052695 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.0 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.0 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.0 | 0.0 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.3 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.0 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.0 | 0.0 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.0 | 0.4 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.1 | GO:0051958 | methotrexate transport(GO:0051958) |
0.0 | 0.1 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.0 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.5 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.6 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.0 | 0.0 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.0 | 0.1 | GO:1900364 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 2.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 1.0 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.3 | 2.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.2 | 1.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 1.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 0.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 1.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 0.5 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 4.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 2.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.4 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.1 | 1.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.6 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.4 | GO:0036019 | endolysosome(GO:0036019) |
0.1 | 0.5 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.1 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.6 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 1.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.4 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.1 | 1.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) inhibin A complex(GO:0043512) |
0.1 | 0.6 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 2.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.4 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 1.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 1.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.5 | GO:0071914 | prominosome(GO:0071914) |
0.1 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.5 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 1.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.6 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.4 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 2.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.1 | 2.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 2.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 0.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 1.0 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.3 | GO:1990794 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.9 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.1 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 0.4 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 1.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.3 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.7 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.3 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 2.7 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.1 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.7 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.9 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 1.5 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.3 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 1.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 1.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.0 | 0.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 1.0 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 1.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.0 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 1.3 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.4 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 2.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.0 | 0.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 1.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.0 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 1.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.1 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.0 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 1.4 | GO:0031228 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.0 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.2 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.7 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 1.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 1.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0048500 | signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 1.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 1.3 | GO:0005930 | axoneme(GO:0005930) |
0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.0 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.0 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.0 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 1.9 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.0 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.6 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 2.1 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.3 | GO:0097346 | INO80-type complex(GO:0097346) |
0.0 | 0.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.5 | 2.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.5 | 1.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.4 | 1.3 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.4 | 1.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 1.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 1.0 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.3 | 0.7 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.3 | 1.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.3 | 1.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 1.9 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 0.8 | GO:0045352 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 receptor antagonist activity(GO:0005152) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
0.3 | 0.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 1.0 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 0.7 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.2 | 0.7 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.2 | 5.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 1.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.7 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 1.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 1.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.2 | 0.9 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.2 | 0.6 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.2 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 1.9 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 1.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.8 | GO:0032029 | myosin tail binding(GO:0032029) |
0.2 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.7 | GO:0070976 | TIR domain binding(GO:0070976) |
0.2 | 0.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.2 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.8 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 0.5 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.2 | 1.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 0.5 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 0.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.2 | 2.0 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.4 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.1 | 0.4 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 1.7 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 1.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.4 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.1 | 1.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 1.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 0.5 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.5 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 0.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.6 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.1 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 2.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 3.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.5 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 1.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 1.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.3 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.1 | 1.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 1.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.3 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.4 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.1 | 0.3 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.1 | 1.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.4 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 1.0 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.3 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 2.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.3 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 0.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.5 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 0.7 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.8 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.1 | 0.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.3 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.3 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 2.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 2.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 2.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.2 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.3 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 1.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.4 | GO:0015100 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 1.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 4.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 11.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 2.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.1 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 1.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.2 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.2 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.1 | 0.2 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.1 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.2 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.1 | 0.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 1.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.1 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.1 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 2.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.1 | 1.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.5 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 0.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.1 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0030977 | taurine binding(GO:0030977) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) L-tyrosine transmembrane transporter activity(GO:0005302) |
0.0 | 0.1 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.0 | 0.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 1.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.3 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.6 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 3.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.0 | 0.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0047237 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.0 | 0.1 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.0 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 1.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 0.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.0 | 0.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 1.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 1.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.8 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.0 | 1.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.0 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.0 | 1.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 1.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.5 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 1.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 1.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.0 | 0.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.0 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.4 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.1 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 1.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.3 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.0 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.0 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.3 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 2.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.0 | 0.0 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.0 | 0.1 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.0 | 0.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.1 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.3 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 1.0 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.0 | 0.1 | GO:0046911 | metal chelating activity(GO:0046911) |
0.0 | 0.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.0 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.0 | 0.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.0 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.0 | 0.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.3 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.0 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.0 | 0.1 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.0 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.5 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.0 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 1.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
0.0 | 0.0 | GO:0050436 | microfibril binding(GO:0050436) |
0.0 | 0.1 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 3.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 4.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 2.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 2.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 2.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 1.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 6.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 1.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.9 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 2.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 7.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 3.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.0 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 2.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 2.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 1.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.4 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.1 | 1.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 2.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 5.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.0 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 1.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 1.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 1.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 1.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 1.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.8 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 1.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 1.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.2 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |